title: Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease.
authors.affiliation: Department of Medicine, Imperial College London, London, UK;
authors.forename: Simon D
authors.initials: SD
authors.lastname: Taylor-Robinson
authors.affiliation: Imperial College London, London, UK.
authors.forename: Jessica
authors.initials: J
authors.lastname: Wong
authors.affiliation: Imperial College London, London, UK.
authors.forename: Mary M E
authors.initials: MM
authors.lastname: Crossey
authors.affiliation: Imperial College London, London, UK.
authors.forename: Shahid A
authors.initials: SA
authors.lastname: Khan
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000401:mortality*; D055088:Early Detection of Cancer; D006801:Humans; D008107:Liver Diseases / Q000150:complications*; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000401:mortality*; D008403:Mass Screening